Stock Groups

Dollar Down, but Hits One-Month High Against Yen Over Rate Hike Bets -Breaking

[ad_1]

© Reuters.

By Gina Lee

Investing.com – The dollar was down on Tuesday morning in Asia but climbed to its strongest level in more than a month against the Japanese yen. An overnight rise in U.S. Treasury yields due to investors betting on an early U.S. Federal Reserve increase in interest rates gave the U.S. dollar a little boost.

By 8:52 ET (11:52 GMT), the that monitors the greenback against other currencies fell 0.04% (1:52 GMT)

It climbed 0.9% to 115.43

With the Australian dollar at a near-two week low of $0.7184, the pair edged higher by 0.13 percent to 0.7200. The pair increased by 0.7% to 0.6789

This pair rose 0.32%, to 6.3727. The release earlier in the day revealed that December’s 50.9 was better than expected.

The exchange rate climbed 0.07% to 1.3481. From Monday when the pair fell to $1.3431, it was unchanged.

After a vacation, the markets of Australia, Japan and China were all reopened.

As a result of long-term U.S. Treasury Yields jumping 12.5 basis point overnight to reach 1.6420%, the dollar rose to 115.395 dollars for the very first time since Nov. 25.

The Fed is expected to raise interest rates by 2022. Investors continue to believe this, and money markets are pricing in an initial hike in May as well as two additional hikes by 2022.

Shinichiro Kadota (Barclays senior FX strategist) said that “the market is pricing in a more aggressive U.S. rates hike scenario or at minimum the risk thereof in 2022 and that certainly remains the key support to the dollar.”

Global COVID-19-related cases continue to increase, in part due to the new omicron version. The delays in global travel and public services are continuing. This surge is also expected to slow down the opening of some U.S. schools following the holiday season.

Investors remained optimistic that the lockdowns would be avoided. On Monday, however, the U.S. Food and Drug Administration approved a third dosage of the drug. Pfizer Inc. (NYSE.:)/ BioNTechSE (F.:) The COVID-19 vaccine is for children 12-15 years old. Also, the regulator shortened the waiting time for booster shots from six to five months following primary doses.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]